This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gravholt, C. H. Articles by Christiansen, J. S. Search for Related Content PubMed PubMed Citation Articles by Gravholt, C. H. Articles by Christiansen, J. S.

Marked Disproportionality in Bone Size and Mineral, and Distinct Abnormalities in Bone Markers and Calcitropic Hormones in Adult Turner Syndrome: A Cross-Sectional Study

Medical Department M (Endocrinology and Diabetes) and Medical Research Laboratories (C.H.G., J.S.C.), and Department of Clinical Chemistry (A.L.L.), Aarhus Kommunehospital, Aarhus University Hospital, DK-8000 Aarhus C, Denmark; Department of Endocrinology (K.B.), Odense University Hospital, DK-5000 Odense C, Denmark; and Departments of Endocrinology and Metabolism (K.B., L.M.) and Clinical Chemistry (L.H.), Aarhus Amtssygehus, Aarhus University Hospital, DK-8000 Aarhus C, Denmark

Address all correspondence and requests for reprints to: Claus Højbjerg Gravholt, M.D., Ph.D., Medical Department M (Endocrinology and Diabetes) and Medical Research Laboratories, Aarhus Kommunehospital, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. E-mail: . ch.gravholt{at}dadlnet.dk

Abstract

Most women with Turner syndrome (TS) have no gonadal activity and thus lack estrogen. Bone mineral density (BMD) is often reduced, leading to an increased risk of osteoporosis and fractures. However, growth retardation with reduced final height and other endocrine disturbances may compromise interpretation of skeletal measurements. The aim of the present study was to explore skeletal findings, bone metabolism, and calcium homeostasis in TS. Sixty women with TS (age, 37 ± 9 yr) and 181 normal age-matched female controls were studied. Bone area (A; square centimeters), bone mineral content (BMC; grams), area-adjusted BMD (aBMD; grams/square centimeter), and volumetric BMD (vBMD; grams/cubic centimeter) were measured at lumbar spine, femoral neck, and forearm using dual energy x-ray absorptiometry. Twenty-eight percent had osteopenia, and 23% had osteoporosis, according to World Health Organization criteria. At the lumbar spine, A, BMC, aBMD, and vBMD were reduced by 18, 27, 11, and 6%, respectively; at the femoral neck, A, BMC, and aBMD were reduced by 2, 10, and 8%, respectively, whereas the 9% reduction in vBMD was insignificant (P = 0.07); and in the forearm, A, BMC, and aBMD were reduced by 53, 55, and 9%, respectively. Bone markers indicated an enhanced bone resorption (21 and 23% increase in C-terminal and N-terminal cross-linking telopeptides of type I collagen/creatinine, respectively) with unchanged (osteocalcin, procollagen I N-terminal propeptide) or reduced (54% reduction in bone alkaline phosphatase) bone formation. Plasma levels of calcium and 25-hydroxyvitamin D (26%) were reduced, and PTH levels increased (74%) in TS. IGF-I (30%), IGF binding protein 3 (18%), testosterone (50%), and SHBG (40%) were reduced in TS.

In summary, A, BMC, and aBMD were found to be universally reduced in TS, whereas vBMD was slightly reduced in the spine. Increased resorption of bone was present, with normal or blunted bone formation, suggesting uncoupling or imbalance in bone remodeling. Skeletal changes may be induced by chromosome abnormalities or by secondary endocrine or metabolic changes related to a relative estrogen deficiency, testosterone deficiency, reduced IGF-I, low vitamin D status, and secondary hyperparathyroidism.

This article has been cited by other articles:

				C. H. Gravholt, H. E. Poulsen, P. Ott, J. S. Christiansen, and H. Vilstrup Quantitative liver functions in Turner syndrome with and without hormone replacement therapy Eur. J. Endocrinol., June 1, 2007; 156(6): 679 - 686. [Abstract] [Full Text] [PDF]

				C. A. Bondy and for The Turner Syndrome Consensus Study Group Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, B. E. Hjerrild, L. Mosekilde, T. K. Hansen, L. M. Rasmussen, J. Frystyk, A. Flyvbjerg, and J. S. Christiansen Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol., October 1, 2006; 155(4): 583 - 592. [Abstract] [Full Text] [PDF]

				K. Stochholm, S. Juul, K. Juel, R. W. Naeraa, and C. Hojbjerg Gravholt Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3897 - 3902. [Abstract] [Full Text] [PDF]

				B. H. Doswell, J. Visootsak, A. N. Brady, and J. M. Graham Jr Turner Syndrome: An Update and Review for the Primary Pediatrician Clinical Pediatrics, May 1, 2006; 45(4): 301 - 313. [Abstract] [PDF]

				W. Hogler, J. Briody, B. Moore, S. Garnett, P. W. Lu, and C. T. Cowell Importance of Estrogen on Bone Health in Turner Syndrome: A Cross-Sectional and Longitudinal Study Using Dual-Energy X-Ray Absorptiometry J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 193 - 199. [Abstract] [Full Text] [PDF]

				V. K. Bakalov, L. Axelrod, J. Baron, L. Hanton, L. M. Nelson, J. C. Reynolds, S. Hill, J. Troendle, and C. A. Bondy Selective Reduction in Cortical Bone Mineral Density in Turner Syndrome Independent of Ovarian Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5717 - 5722. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, R. W. Naeraa, K. Brixen, K. W. Kastrup, L. Mosekilde, J. O. L. Jorgensen, and J. S. Christiansen Short-Term Growth Hormone Treatment in Girls With Turner Syndrome Decreases Fat Mass and Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Pediatrics, November 1, 2002; 110(5): 889 - 896. [Abstract] [Full Text] [PDF]